Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CODAvision: best practices and a user-friendly interface for rapid, customizable segmentation of medical images.

Nature protocols·2026
Same author

Serum CA19.9 for Detecting High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm: A Systematic Review and Meta-Analysis.

JAMA network open·2026
Same author

Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progression.

Cell press blue·2026
Same author

Polyunsaturated fatty acid and oxylipin profiles of Angiostrongylus cantonensis during cerebral-to-pulmonary migration illuminate parasite and host microenvironmental lipid signatures.

Parasites & vectors·2026
Same author

CLOVER: An analysis protocol for visualization and identification of cell clusters through cluster overlaying for imaging mass cytometry.

STAR protocols·2026
Same author

The want for Wnt: Pancreatic cancer assembles a self-sustaining Wnt-signaling ecosystem.

Developmental cell·2026

Related Experiment Video

Updated: May 27, 2025

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

9.3K

SVCFit: Inferring structural variant cellular fraction in tumors.

Yunzhou Liu, Jiaying Lai, Laura D Wood

    Biorxiv : the Preprint Server for Biology
    |February 20, 2025
    PubMed
    Summary

    SVCFit accurately estimates structural variant cellular prevalence in tumors, improving clonal reconstruction. This method enhances understanding of tumor evolution and genomic instability without needing tumor purity information.

    More Related Videos

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
    08:08

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

    Published on: February 27, 2015

    16.1K
    Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
    10:57

    Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

    Published on: August 14, 2018

    10.6K

    Related Experiment Videos

    Last Updated: May 27, 2025

    Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
    11:27

    Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

    Published on: September 22, 2013

    9.3K
    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
    08:08

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

    Published on: February 27, 2015

    16.1K
    Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
    10:57

    Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

    Published on: August 14, 2018

    10.6K

    Area of Science:

    • Genomics
    • Cancer Biology
    • Bioinformatics

    Background:

    • Tumor evolution is driven by cellular mutation and selection, leading to subclones competing for dominance.
    • Structural variants (SVs) offer insights into tumor evolution, genomic instability, and late-stage tumor development.
    • Accurate identification and quantification of subclones are crucial for understanding tumor heterogeneity.

    Purpose of the Study:

    • To present SVCFit, a scalable computational method for estimating the cellular prevalence of somatic structural variants (deletions, duplications, inversions).
    • To demonstrate improved accuracy in cellular prevalence estimation by incorporating distinct read patterns for different SV types.
    • To validate SVCFit's performance using simulated data and patient-derived metastatic samples.

    Main Methods:

    • Developed SVCFit, a scalable algorithm to estimate cellular prevalence of somatic deletions, duplications, and inversions.
    • Incorporated distinct read patterns specific to each structural variant type to enhance estimation accuracy.
    • Validated the method on simulated datasets and real patient metastatic samples with known mixture proportions.

    Main Results:

    • SVCFit significantly improves the accuracy of structural variant cellular prevalence estimation compared to state-of-the-art methods (p<0.05).
    • The method achieves high accuracy without requiring prior knowledge of tumor purity, overcoming limitations of inaccurate purity estimates.
    • SVCFit demonstrates robust performance across simulated and real-world cancer genomic data.

    Conclusions:

    • SVCFit provides a more accurate and accessible approach for structural variant-based clonal reconstruction.
    • The scalability and speed of SVCFit make it suitable for large cohort analysis using cost-effective bulk whole-genome sequencing (WGS).
    • This advancement enhances the study of tumor evolution, genomic instability, and cancer subclonal architecture.